Depression and low testosterone share a frustrating amount of common ground. Both produce fatigue, low motivation, reduced interest in activities, and emotional flatness. This overlap means that one condition is frequently attributed to the other, or that both exist simultaneously without the hormonal component being identified or addressed. The relationship between testosterone and mood is real, biologically grounded, and clinically relevant, but it is also more nuanced than a simple cause-and-effect statement captures. This article explains what the research shows, how testosterone influences brain chemistry, and what it means for men who may be experiencing both conditions. For more on the wider effects of testosterone on male health, see our article on what testosterone does for men.
The Research: Does Low Testosterone Cause Depression?
Multiple observational studies have found significant associations between low testosterone and depressive symptoms in men. A meta-analysis published in the Journal of Psychiatric Practice examined data from multiple controlled trials and found that men with low testosterone had significantly higher rates of depressive symptoms compared to men with normal levels ( 1 ). This association holds across age groups, though it is particularly well-documented in middle-aged and older men.
The relationship is bidirectional. Depression itself affects the HPG axis; the stress response, elevated cortisol, and disrupted sleep that accompany depression all suppress testosterone. This creates a cycle where low testosterone contributes to mood dysregulation, and the downstream effects of mood dysregulation further suppress testosterone. Distinguishing which came first in a given patient is often clinically challenging.
Importantly, association does not prove causation at the individual level. Not all men with low testosterone develop depression, and not all depressed men have low testosterone. Testosterone is one of many factors that influence mood, and depression is a complex condition with genetic, psychological, environmental, and biological contributors ( 2 ).
How Testosterone Influences Brain Chemistry
Testosterone receptors are distributed throughout the brain, including in the amygdala (involved in emotional processing), hippocampus (involved in memory and mood regulation), and prefrontal cortex (involved in executive function and impulse control). Testosterone influences mood through several intersecting neurobiological mechanisms ( 1 ).
Testosterone modulates dopamine signaling. Dopamine is the neurotransmitter most closely associated with motivation, reward, and pleasure. Low dopamine activity is a well-established feature of depression. Testosterone appears to upregulate dopamine receptor sensitivity and support dopamine release in key brain circuits, which helps explain why low testosterone is associated with reduced motivation and anhedonia (the inability to experience pleasure) ( 2 ).
Testosterone also influences serotonin metabolism and the activity of monoamine oxidase (MAO), an enzyme that breaks down serotonin and dopamine. Some research suggests that testosterone reduces MAO activity, preserving higher levels of mood-stabilizing neurotransmitters. Estradiol, which is produced from testosterone via aromatase, also has important neuroprotective and mood-supporting effects in men.
Does Testosterone Therapy Improve Depression?
Several clinical trials have examined the effect of testosterone therapy on depressive symptoms in men with hypogonadism. A meta-analysis published in JAMA Psychiatry in 2019 found that testosterone treatment was associated with significant reductions in depressive symptoms compared to placebo in men with low testosterone ( 3 ). The effect size was meaningful, comparable in some analyses to antidepressant medications.
However, the evidence is more mixed for men with normal testosterone levels. Testosterone therapy in eugonadal (normal-testosterone) depressed men shows inconsistent results. This supports the interpretation that the antidepressant effect of TRT is at least partly dependent on correcting a genuine hormonal deficiency rather than simply elevating testosterone per se.
It is also important to note that TRT is not a replacement for psychiatric evaluation and treatment of depression. In men who have both low testosterone and clinical depression, addressing both simultaneously, with appropriate medication and/or therapy for the depression and treatment for the hormonal deficiency, typically produces better outcomes than addressing either alone.
Symptoms That Overlap: How to Tell the Difference
Some symptoms are common to both low testosterone and depression: fatigue, low motivation, reduced libido, sleep disturbance, and emotional blunting. Symptoms that are more specific to low testosterone include reduced muscle mass, increased body fat, decreased bone density, reduced morning erections, and testicular shrinkage. Symptoms more specific to depression include persistent sadness or hopelessness, loss of interest in previously enjoyable activities unrelated to physical performance, and passive or active thoughts of self-harm.
In practice, a man presenting with several of the shared symptoms should have both a hormonal evaluation and a mental health assessment. Treating the hormonal component without evaluating the psychiatric component, and vice versa, risks leaving one driver untreated.
Common Myths About Low Testosterone and Depression
A common myth is that if testosterone levels are normal, low testosterone cannot be contributing to mood problems. Normal range is wide, and a man who was previously functioning at a higher testosterone level within the normal range may experience mood changes when levels decline, even if they remain technically “in range.” Symptom context matters alongside lab values.
Another misconception is that testosterone therapy alone can cure depression. TRT can meaningfully improve mood and reduce depressive symptoms in men with genuine hypogonadism, but depression is a complex condition and most cases require a comprehensive approach. For men experiencing significant depressive symptoms, professional mental health care should be part of the plan.
When to See a Provider
If you are experiencing persistent low mood, fatigue, loss of motivation, or other depressive symptoms, seeking evaluation is important both for mental health reasons and to rule out hormonal contributions. A men’s health provider can assess testosterone levels alongside a mental health professional’s evaluation of depression, ensuring both pathways are addressed.
To understand how low testosterone is diagnosed and what the treatment options look like, exploring those topics alongside a mental health evaluation gives you the most complete picture. If you are experiencing symptoms, speaking with a men’s health provider is the right first step.
Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
References
- Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. 2009;15(4):289-305. https://doi.org/10.1097/01.pra.0000358315.88931.fc
- McHenry J, Carrier N, Hull E, Kabbaj M. Sex differences in anxiety and depression: role of testosterone. Front Neuroendocrinol. 2014;35(1):42-57. https://doi.org/10.1016/j.yfrne.2013.09.001
- Walther A, Breidenstein J, Miller R. Association of testosterone treatment with alleviation of depressive symptoms in men: a systematic review and meta-analysis. JAMA Psychiatry. 2019;76(1):31-40. https://doi.org/10.1001/jamapsychiatry.2018.2734
- Shores MM, Sloan KL, Matsumoto AM, Moceri VM, Felker B, Kivlahan DR. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry. 2004;61(2):162-167. https://doi.org/10.1001/archpsyc.61.2.162
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://doi.org/10.1210/jc.2018-00229